Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review Hans-Jürgen MöllerPeter Falkai Editorial Open access 15 February 2023 Pages: 1 - 3
Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis Yazmin Hernández-DíazCarlos Alfonso Tovilla-ZárateThelma Beatriz González-Castro Original Paper 10 October 2022 Pages: 5 - 14
Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD Gabriela Pessin MeyerBruna Santos da SilvaClaiton Henrique Dotto Bau Original Paper 12 March 2022 Pages: 15 - 24
Working memory dysfunction in fibromyalgia is associated with genotypes of the catechol- O-methyltransferase gene: an event-related potential study David FerreraFrancisco Gómez-EsquerFrancisco Mercado Original Paper Open access 13 September 2022 Pages: 25 - 40
Temperament traits mediate the relationship between CACNA1C polymorphisms and bipolar disorder in cisgender women Clarissa Ribeiro BastosBertha Bueno BockGabriele Ghisleni Original Paper 01 October 2022 Pages: 41 - 50
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited Lucie BartovaMarkus DoldSiegfried Kasper Original Paper Open access 09 March 2022 Pages: 51 - 63
Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data Mateo de BardeciWaldemar GreilJohanna Seifert Original Paper Open access 25 February 2022 Pages: 65 - 74
Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder X. M. HartS. HeesenU. Havemann-Reinecke Original Paper Open access 07 October 2022 Pages: 75 - 83
Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol Esther DechantsreiterFrank PadbergMor Nahum Original Paper Open access 22 October 2022 Pages: 85 - 98
Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation Haejin HongRye Young KimSuji Lee Original Paper 11 August 2022 Pages: 99 - 111
Predicting treatment outcome in depression: an introduction into current concepts and challenges Nicolas RostElisabeth B. BinderTanja M. Brückl Original Paper Open access 19 May 2022 Pages: 113 - 127
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials Giordano Novak RossiJaime E. C. HallakRafael G. dos Santos Invited Review 13 July 2022 Pages: 129 - 155
Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis Irina S. BokshaMaria A. Omel’chenkoGulnur Sh. Burbaeva Original Paper 15 March 2022 Pages: 157 - 168
Aberrant temporal–spatial complexity of intrinsic fluctuations in major depression Kaizhong ZhengBaojuan LiLingjiang Li Original Paper 13 April 2022 Pages: 169 - 181
Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study Chuanyi KangJiacheng LiuXiangyang Zhang Original Paper 12 May 2022 Pages: 183 - 190
Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder Wanqiu YangMiao QuXiang-Yang Zhang Original Paper 18 July 2022 Pages: 191 - 198
Metabolic parameters and thyroid hormones in relation to suicide attempts in patients with first-episode and drug-naive major depressive disorder with comorbid glucose disturbances: a large cross-sectional study Shi wang ChenXue LiXiang-yang Zhang Original Paper 20 September 2022 Pages: 199 - 207
No effects of acute tryptophan depletion on anxiety or mood in weight-recovered female patients with anorexia nervosa Tomas WeinertFabio BernardoniStefan Ehrlich Original Paper Open access 05 May 2022 Pages: 209 - 217
Dementia risk in middle-aged patients with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of 84,824 subjects Ying-Jay LiouShih-Jen TsaiMu-Hong Chen Original Paper 26 April 2022 Pages: 219 - 227
Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer’s disease Riccardo MancaJose Manuel Valera-Bermejofor the Alzheimer’s Disease Neuroimaging Initiative Original Paper Open access 13 May 2022 Pages: 229 - 241
Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis Jose ContadorAna Magdalena Vargas-MartínezAlbert Lladó Original Paper 16 June 2022 Pages: 243 - 252
The neural signatures of psychoses in Alzheimer’s disease: a neuroimaging genetics approach Riccardo MancaAntonio F. Pardiñasfor the Alzheimer’s Disease Neuroimaging Initiative Original Paper Open access 21 June 2022 Pages: 253 - 267
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice Martina StaziSilvia ZamparOliver Wirths Original Paper Open access 09 June 2022 Pages: 269 - 281
Canonical insulin signaling is not significantly impaired in early stages of depression Deepti SinghHenrik DobrowolnyJohann Steiner Short Communication 07 May 2022 Pages: 283 - 286
